tiprankstipranks
Lite Strategy Inc (LITS)
NASDAQ:LITS

Lite Strategy (LITS) Price & Analysis

Compare
1,051 Followers

LITS Stock Chart & Stats

$1.33
--
Market closed
$1.33
--

Bulls Say, Bears Say

Bulls Say
Low Leverage / Zero DebtZero reported debt in 2024–2025 materially reduces short-term solvency risk and interest burden. This gives management optionality to raise capital, restructure operations, or prioritize investments without servicing debt, preserving flexibility through the next several quarters.
Board Continuity And Governance ActionsShareholder approval of directors, auditor ratification, and an omnibus equity plan signal governance stability and a framework for executive alignment. These structural governance items support consistent oversight and talent retention, reducing governance risk over a multi-month horizon.
Prior Revenue Growth And 2024 ProfitabilityThe company demonstrated the ability to scale revenue and generate profits through 2024, evidencing prior product-market traction and operational capability. This historical profitability implies an underlying business model that can be reactivated if execution or market issues are addressed.
Bears Say
2025 Revenue Collapse And Large LossA complete revenue drop to zero and a material net loss represent a structural failure in commercial execution or product availability. Such a reversal impairs predictability, undermines customer relationships, and can take many quarters to restore even with corrective actions.
Sustained Negative Cash FlowPersistent negative operating and free cash flow, including a -$20.8M FCF in 2025, creates ongoing financing needs. This reduces runway, forces external funding or austerity measures, and constrains investment in R&D or commercialization, pressuring medium-term recovery prospects.
Declining Equity And Negative ROEMeaningful declines in shareholders' equity and negative returns on equity indicate erosion of internal capital and persistent losses. This weakens the balance sheet buffer, limits self-funding capacity, and increases the likelihood of dilutive financing or tougher credit terms over the coming months.

Lite Strategy News

LITS FAQ

What was Lite Strategy Inc’s price range in the past 12 months?
Lite Strategy Inc lowest stock price was $0.95 and its highest was $9.00 in the past 12 months.
    What is Lite Strategy Inc’s market cap?
    Lite Strategy Inc’s market cap is $43.63M.
      When is Lite Strategy Inc’s upcoming earnings report date?
      Lite Strategy Inc’s upcoming earnings report date is May 07, 2026 which is in 41 days.
        How were Lite Strategy Inc’s earnings last quarter?
        Lite Strategy Inc released its earnings results on Feb 05, 2026. The company reported -$0.824 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.824.
          Is Lite Strategy Inc overvalued?
          According to Wall Street analysts Lite Strategy Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Lite Strategy Inc pay dividends?
            Lite Strategy Inc pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Lite Strategy Inc dividends here
              What is Lite Strategy Inc’s EPS estimate?
              Lite Strategy Inc’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Lite Strategy Inc have?
              Lite Strategy Inc has 36,362,000 shares outstanding.
                What happened to Lite Strategy Inc’s price movement after its last earnings report?
                Lite Strategy Inc reported an EPS of -$0.824 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.283%.
                  Which hedge fund is a major shareholder of Lite Strategy Inc?
                  Currently, no hedge funds are holding shares in LITS
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Lite Strategy Inc

                    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

                    Lite Strategy (LITS) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    ABVC BioPharma
                    Jasper Therapeutics
                    Prelude Therapeutics
                    Gain Therapeutics
                    Estrella Immunopharma

                    Ownership Overview

                    10.59%3.33%2.98%80.42%
                    10.59% Insiders
                    2.98% Other Institutional Investors
                    80.42% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks